169 related articles for article (PubMed ID: 20809259)
1. Moderate GSK-3β inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy.
Hoang MV; Smith LE; Senger DR
Angiogenesis; 2010 Sep; 13(3):269-77. PubMed ID: 20809259
[TBL] [Abstract][Full Text] [Related]
2. Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion.
Hoang MV; Smith LE; Senger DR
Biochim Biophys Acta; 2011 Apr; 1812(4):549-57. PubMed ID: 20804843
[TBL] [Abstract][Full Text] [Related]
3. Cdc42-mediated inhibition of GSK-3β improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis.
Hoang MV; Nagy JA; Senger DR
Microvasc Res; 2011 Jan; 81(1):34-43. PubMed ID: 20849862
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory role of miR-203 in the angiogenesis of mice with pathological retinal neovascularization disease through downregulation of SNAI2.
Yu L; Wu S; Che S; Wu Y; Han N
Cell Signal; 2020 Jul; 71():109570. PubMed ID: 32084532
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
6. GSK-3β: a signaling pathway node modulating neural stem cell and endothelial cell interactions.
Li Q; Michaud M; Canosa S; Kuo A; Madri JA
Angiogenesis; 2011 May; 14(2):173-85. PubMed ID: 21253820
[TBL] [Abstract][Full Text] [Related]
7. Influenza A virus infection of vascular endothelial cells induces GSK-3β-mediated β-catenin degradation in adherens junctions, with a resultant increase in membrane permeability.
Hiyoshi M; Indalao IL; Yano M; Yamane K; Takahashi E; Kido H
Arch Virol; 2015 Jan; 160(1):225-34. PubMed ID: 25385175
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
Kaga S; Zhan L; Altaf E; Maulik N
J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
[TBL] [Abstract][Full Text] [Related]
10. Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy.
Abdelsaid MA; Pillai BA; Matragoon S; Prakash R; Al-Shabrawey M; El-Remessy AB
J Pharmacol Exp Ther; 2010 Jan; 332(1):125-34. PubMed ID: 19815813
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium.
Tan J; Geng L; Yazlovitskaya EM; Hallahan DE
Cancer Res; 2006 Feb; 66(4):2320-7. PubMed ID: 16489037
[TBL] [Abstract][Full Text] [Related]
12. The allosteric glycogen synthase kinase-3 inhibitor NP12 limits myocardial remodeling and promotes angiogenesis in an acute myocardial infarction model.
Baruah J; Hitzman R; Zhang J; Chaudhuri S; Mastej V; Wary KK
J Biol Chem; 2017 Dec; 292(50):20785-20798. PubMed ID: 29070680
[TBL] [Abstract][Full Text] [Related]
13. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.
Yao YY; Yin H; Shen B; Smith RS; Liu Y; Gao L; Chao L; Chao J
Cardiovasc Res; 2008 Dec; 80(3):354-64. PubMed ID: 18689794
[TBL] [Abstract][Full Text] [Related]
14. SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization.
Kim KL; Seo S; Kim JT; Kim J; Kim W; Yeo Y; Sung JH; Park SG; Suh W
Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2120-2131. PubMed ID: 31434494
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of protein kinase CK2 suppresses angiogenesis and hematopoietic stem cell recruitment to retinal neovascularization sites.
Kramerov AA; Saghizadeh M; Caballero S; Shaw LC; Li Calzi S; Bretner M; Montenarh M; Pinna LA; Grant MB; Ljubimov AV
Mol Cell Biochem; 2008 Sep; 316(1-2):177-86. PubMed ID: 18612802
[TBL] [Abstract][Full Text] [Related]
16. 4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.
Gebhardt R; Lerche KS; Götschel F; Günther R; Kolander J; Teich L; Zellmer S; Hofmann HJ; Eger K; Hecht A; Gaunitz F
J Cell Mol Med; 2010 Jun; 14(6A):1276-93. PubMed ID: 19228266
[TBL] [Abstract][Full Text] [Related]
17. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
Neelam S; Brooks MM; Cammarata PR
Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
[TBL] [Abstract][Full Text] [Related]
18. Glycogen Synthase Kinase 3β Inhibition Improves Myocardial Angiogenesis and Perfusion in a Swine Model of Metabolic Syndrome.
Potz BA; Sabe AA; Elmadhun NY; Clements RT; Robich MP; Sodha NR; Sellke FW
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27405812
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GSK-3β Activation Protects SD Rat Retina Against N-Methyl-N-Nitrosourea-Induced Degeneration by Modulating the Wnt/β-Catenin Signaling Pathway.
Wang B; Hu C; Yang X; Du F; Feng Y; Li H; Zhu C; Yu X
J Mol Neurosci; 2017 Oct; 63(2):233-242. PubMed ID: 28929374
[TBL] [Abstract][Full Text] [Related]
20. Ascl1a/Dkk/beta-catenin signaling pathway is necessary and glycogen synthase kinase-3beta inhibition is sufficient for zebrafish retina regeneration.
Ramachandran R; Zhao XF; Goldman D
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15858-63. PubMed ID: 21911394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
